Showing 18 of 18 recruiting trials for “mucinous-cystadenocarcinoma-of-the-pancreas”
RecruitingNCT07216521 ↗
Intent of Surgery for IPMN
RecruitingNCT07117045 ↗
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
👨⚕️ Jeremie Calais, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT06574373 ↗
Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
👨⚕️ Carmine Carbone, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS📍 2 sites📅 Started May 2025View details ↗
RecruitingNCT06694792 ↗
Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium
Ivonescimab in the Treatment of Multiple Advanced Tumors
Enrolling by InvitationNCT06276764 ↗
The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
RecruitingNCT06638866 ↗
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
Enrolling by InvitationNCT06283576 ↗
Pancreatic Cancer Initial Detection Via Liquid Biopsy
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RecruitingNCT05433935 ↗
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RecruitingNCT05117723 ↗
Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
RecruitingNCT06706700 ↗
Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas
RecruitingNCT04275557 ↗
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
👨⚕️ Andrea B Apolo, Alliance for Clinical Trials in Oncology📍 580 sites📅 Started May 2019View details ↗
RecruitingNCT03492151 ↗
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →